Telo Genomics Corp. is a molecular diagnostics company, which engages in the development of telomere analysis platforms in the industry. Its products include Telomere Science and Teloview. The company was founded by Sabine Mai on May 25, 2011 and is headquartered in Toronto, Canada.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Telo Genomics Corp market cap is $2.54M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Telo Genomics Corp 52 week high is $0.0567 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Telo Genomics Corp 52 week low is $0.0182 as of November 18, 2026.
Telo Genomics Corp stock price today is $0.0253.
Telo Genomics Corp stock price yesterday was $0.0296.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Telo Genomics Corp's P/E ratio is -1.51.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Telo Genomics Corp P/B ratio is -2.2772.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Telo Genomics Corp 50-day moving average is $0.0361.